Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Albuterol recalled?

Yes — there is an active recall. 6 ongoing FDA recalls mention Albuterol (42 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Albuterol. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Albuterol recalls on record

none so far in 2026; 42 on record, newest first
Class II · Moderate risk

Ventolin HFA

Defective Delivery System: Elevated number of units with out of specification results for leak rate

Ongoing Packaging defect GlaxoSmithKline, LLC NDC 0173-0682-20 D-0793-2017
Class II · Moderate risk

Ventolin HFA

Defective Delivery System: Elevated number of units with out of specification results for leak rate.

Ongoing Packaging defect GlaxoSmithKline, LLC NDC 0173-0682-20 D-0626-2017
Class II · Moderate risk

Albuterol Sulfate Syrup

Presence of Foreign Substance; presence of black particles describes generically as cellulose-based bundles of brown fibrous material.

Terminated Particulate / foreign matter Teva North America NDC 0093-0661-16 D-1455-2016
Class II · Moderate risk

Ventolin HFA

Defective Delivery System: Some canisters may not contain sufficient propellant to deliver the labeled claim of 200 actuations through the end of shelf life.

Terminated Packaging defect GlaxoSmithKline, LLC NDC 0173-0682-20 D-0519-2016
Class II · Moderate risk

Combivent Respimat

Defective Delivery System: Inhalers do not spray properly, emitting either no spray or a short transient spray.

Terminated Packaging defect Boehringer Ingelheim Roxane Inc NDC 0597-0024-02 D-1279-2015
Class II · Moderate risk

Albuterol Sulfate active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-506-2015
Class II · Moderate risk

Albuterol Sulfate Inhalation Solution

Lack of Assurance of Sterility: Nephron Pharmaceuticals Corporation conducted a routine periodic aseptic process simulation and discovered bacterial growth in a number of media fill vials, exceeding the allowable limit.

Terminated Sterility / contamination Nephron Pharmaceuticals Corp. NDC 0487-9501-25 D-66462-001
Class II · Moderate risk

Albuterol Sulfate ER

Labeling: Label Mixup: ALBUTEROL SULFATE ER, Tablet, 4 mg may have potentially been mislabeled as one of the following drugs: SIMVASTATIN, Tablet, 20 mg, NDC 16714068303, Pedigree: W003580, EXP: 6/24/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-907-2014
Class II · Moderate risk

Ventolin HFA

Does Not Deliver Proper Metered Dose: Potential content of albuterol per dose is below specification.

Terminated Other GlaxoSmithKline Inc NDC 0173-0682-20 D-1666-2012